动态系统评价的研究现状与进展

中国药物评价 ›› 2021, Vol. 38 ›› Issue (6): 471-478.

所属专题：专栏——动态系统评价

• 专栏——动态系统评价 • 上一篇下一篇

动态系统评价的研究现状与进展

郑卿勇1，程露颖1,2，许建国3，肖月4,5，雷云飞6，李江7*，田金徽3,8*

1.兰州大学循证护理中心，兰州大学护理学院，甘肃兰州 730000； 2.自贡市第一人民医院，四川自贡 643000; 3.兰州大学循证医学中心，兰州大学基础医学院，甘肃兰州 730000； 4.国家卫生健康委卫生发展研究中心, 北京 100191； 5.国家卫生健康委国家药物和卫生技术综合评估中心, 北京 100191； 6.锦州医科大学医疗学院，辽宁锦州 121000； 7.国家癌症中心，国家肿瘤临床医学研究中心，中国医学科学院北京协和医学院肿瘤医院癌症早诊早治办公室，北京 100021; 8.甘肃省循证医学与临床转化重点实验室，甘肃兰州 730000

收稿日期:2021-10-21 修回日期:2021-11-23 出版日期:2021-12-28 发布日期:2021-12-28
基金资助:
中国医学科学院中央级公益性科研院所基本科研专项（项目编号:2020-PT330-001;项目名称:中国癌症防控循证证据库建立及指导下的癌症筛查效果与可持续发展评价研究）；甘肃省科技厅软科学专项（项目编号:20CX4ZA027;项目名称:中国循证社会科学发展对策研究）；甘肃省科技计划项目（项目编号:20CX9ZA112;项目名称:基于循证医学证据的妊娠期用药数据库管理研究）；国家卫生健康委药政司科研项目（项目编号:CNHDRC-KT-2-2021-49;项目名称:基于我国临床真实世界数据开展儿童药品临床综合评价的标准技术路径及方法研究）

Research Status and Progress of Living Systematic Review

1.Evidence-based Nursing Center, School of Nursing, Lanzhou University, Gansu Lanzhou 730000，China; 2.Zigong First People′s Hospital, Sichuan Zigong 643000, China. 3.Evidence-Based Medicine Center，School of Basic Medical Sciences，Lanzhou University，Gansu Lanzhou 730000，China; 4.China National Health Development Research Center, Beijing 100191, China; 5.National Center for Drug and Technology Assessment, Beijing 100191, China; 6.Medical College of Jinzhou Medical University, Liaoning Jinzhou 121000, China； 7.Office of Cancer Screening, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China; 8.Key Laboratory of Evidence-based Medicine and Knowledge Translation of Gansu Province, Gansu Lanzhou 730000, China

Received:2021-10-21 Revised:2021-11-23 Online:2021-12-28 Published:2021-12-28
Contact: Tian jinhui E-mail:tjh996@163.com

摘要/Abstract

摘要： 目的：全面分析动态系统评价（Living systematic reviews，LSR）研究的主题与进展，以期了解动态系统评价的研究现状与发展方向，为国内学者开展LSR研究提供相关参考与指引。方法：检索4大主要英文数据库，纳入动态系统评价的相关文献研究。借助Excel 2016软件提取与分析发文作者、发表年代、更新频次、期刊类型与研究热点分类等信息，通过VOSviewer1.6.15软件对研究作者与纳入该研究的关键词等内容进行整合，生成聚类分析的网络知识图谱。结果：筛选后最终纳入151篇英文文献，发文数量自2016年起呈快速增长趋势。共有633位作者参与了LSR相关研究的撰写，主要作者形成了6个合作团体，合作团体内部联系紧密。纳入的研究刊载在37种期刊上，其中81.1%为SCI期刊，影响因子最高期刊为BMJ（IF=30.313）。研究主题主要包括新型冠状病毒、创伤性颅脑损伤、LSR方法学研究、儿童生长发育以及疾病预后相关知识等，各类文献的研究重点在于通过LSR的研究方法指导当前热点疾病治疗证据的动态整合与更新，但目前LSR动态更新方式尚不规范。结论：发文量基本呈现逐年上涨的趋势，近年增长趋势明显，高产作者、国家与机构均较少，各团体间合作不如内部联系紧密，载文期刊多为高质量期刊。LSR研究在国内刚刚起步，具有很大的发展潜力。

关键词: font-size:medium, ">动态系统评价；现状分析

Abstract: Objective： The theme and progress of living systematic reviews (LSR) research were comprehensively analyzed in order to understand the research status and development direction of LSR, aiming to provide relevant reference and guidance for domestic scholars to carry out LSR research.Methods： Four major English database were searched and related literature studies of LSR research were included. With the help of Excel 2016 software, authors, publication years, update frequency, journal types and classification of research hotspots were extracted and analyzed. VOSviewer 1.6.15 software was used to integrate research authors and keywords included in this study, and the network knowledge map of cluster analysis was generated.Results： After screening, 151 English studies were included, and the number of published papers has been increasing rapidly since 2016. A total of 633 authors participated in the LSR related study, and six collaborations were formed among the leading authors, which were connected closely. The included studies were published in 37 journals, of which 81.1% were SCI journals, and the highest impact factor was BMJ (IF=30.313). The research topics mainly include novel coronavirus, traumatic brain injury, LSR methodological research, knowledge of child growth, development and disease prognosis etc.The focus of various studies was to guide the living integration andupdate of the treatment evidence of current hot diseases through themethod of LSR. However, the dynamic updating mode of LSR is not standardized at present. Conclusion： The number of published papers shows a trend of increasing year by year, with obvious growth in recent years. There were fewer prolific authors, countries and institutions, and the cooperation among different groups was not as close as the internal relations. Overall, the quality of published journals was high. LSR research has just started in China and has great potential for development.

Key words: Living systematic reviews, Status analysis

中图分类号:

郑卿勇, 程露颖, 许建国, 肖月, 雷云飞, 李江, 田金徽, . 动态系统评价的研究现状与进展[J]. 中国药物评价, 2021, 38(6): 471-478.

ZHENG Qing-yong, CHEN Lu-ying, XU Jian-guo, XIAO Yue, LEI Yun-fei, LI Jiang, TIAN Jin-hui, . Research Status and Progress of Living Systematic Review[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2021, 38(6): 471-478.

参考文献

[1]Elliott J H, Turner T, Clavisi O, et al. Living systematic reviews:an emerging opportunity to narrow the evidence-practice gap[J].PLoS Med, 2014, 11(2):e1001603.
     [2]Elliott J H, Synnot A, Turner T, et al. Living systematic review:1. Introduction-the why, what, when, and how[J].J Clin Epidemiol, 2017, 91:23-30.
     [3]许吉, 邓宏勇. 动态系统评价简介[J].中国循证医学杂志， 2020, 20(2):244-248.
     [4]Thomas J, Noel-Storr A, Marshall I, et al. Living systematic reviews:2. Combining human and machine effort[J].J Clin Epidemiol, 2017, 91:31-37.
     [5]Simmonds M, Salanti G, Mckenzie J, et al. Living systematic reviews:3. Statistical methods for updating meta-analyses[J].J Clin Epidemiol, 2017, 91:38-46.
     [6]Akl EA, Meerpohl JJ, Elliott J, et al. Living systematic reviews:4. Living guideline recommendations[J].J Clin Epidemiol, 2017, 91:47-53.
     [7]国家卫健委. 关于印发国际疾病分类第十一次修订本(ICD-11) 中文版的通知[EB/OL].(2019-6-30) [2020-03-20]. http://www.nhc.gov.cn/yzygj/s7659/201812/14caf755107c43d2881905a8d4f44ed2.shtml
     [8]Yi-Bing C, Xiao-Fang T, Junge R, et al. Current Research Trends in Traditional Chinese Medicine Formula:A Bibliometric Review from 2000 to 2016[J]. Evid Based Complement Alternat Med[J].2019,3:3961395
     [9]Gao Y, Shi S, Ma W, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer[J]. Int Immunopharmacol，2019, 72:374-384.
     [10]Fu L, Sun Z, He L, et al. Global Long-Term Care Research:A Scientometric Review[J]. Int J Environ Res Public Health， 2019, 16(12):2077
     [11]Gao Y, Ge L, Shi S, et al. Global trends and future prospects of e-waste research:a bibliometric analysis[J]. Environ Sci Pollut Res Int， 2019, 26(17):17809-17820.
     [12]Xuan T B, Van P T, Hai H G, et al. A Bibliometric Analysis of the Global Research Trend in Child Maltreatment[J]. Int J Environ Res Public Health， 2018, 15(7):1456.
     [13]Chen C. CiteSpace II:Detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci，2006, 57(3):359-377.
     [14]Synnot A, Gruen R L, Menon D, et al. A New Approach to Evidence Synthesis in Traumatic Brain Injury:A Living Systematic Review[J].J Neurotrauma, 2016, 38(8):1069-1071.
     [15]John A, Okolie C, Eyles E, et al. The impact of the COVID-19 pandemic on self-harm and suicidal behaviour:a living systematic review[J].F1000Res, 2020, 9:1097.
     [16]Piechotta V, Chai K L, Valk S J, et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19:a living systematic review[J].Cochrane Database Syst Rev, 2020, 7(7):CD013600.
     [17]Russell C D, Millar J E, Baillie J K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J].Lancet, 2020, 395(10223):473-475.
     [18]Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19:a randomised, double-blind, placebo-controlled, multicentre trial[J].Lancet, 2020, 395(10236):1569-1578.
     [19]Lippi G, Plebani M, Henry B M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections:A meta-analysis[J].Clin Chim Acta, 2020, 506:145-148.
     [20]Pereira M, Dantas Damascena A, Galvo Azevedo L M, et al. Vitamin D deficiency aggravates COVID-19:systematic review and meta-analysis[J].Crit Rev Food Sci Nutr, 2020: 1-9.
     [21]Patanavanich R, Glantz S A. Smoking Is Associated With COVID-19 Progression:A Meta-analysis[J].Nicotine Tob Res, 2020, 22(9):1653-1656.
     [22]Chang T H, Wu J L, Chang L Y. Clinical characteristics and diagnostic challenges of pediatric COVID-19:A systematic review and meta-analysis[J].J Formos Med Assoc, 2020, 119(5):982-989.
     [23]Thombs B D, Bonardi O, Rice D B, et al. Curating evidence on mental health during COVID-19:A living systematic review[J].J Psychosom Res, 2020, 133:110-113.
     [24]Shi J, Gao Y, Zhao L, et al. Prevalence of delirium, depression, anxiety, and post-traumatic stress disorder among COVID-19 patients:protocol for a living systematic review[J].Syst Rev, 2020, 9(1):258.
     [25]Shepherd-Banigan M E, Shapiro A, Mcduffie J R, et al. Interventions That Support or Involve Caregivers or Families of Patients with Traumatic Injury:a Systematic Review[J].J Gen Intern Med, 2018, 33(7):1177-1186.

动态系统评价的研究现状与进展

Research Status and Progress of Living Systematic Review

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李川, 杨军令, 程晨, 贾伟伟. 中药新药的药代研究[J]. 中国药物评价, 2023, 40(6): 457-459.
[2]	叶潇, 郑爽#, 林超, 黄舒佳, 王宇, 于敏, 刘颖. 生物分析方法验证及生物样品分析各指导原则间的比较[J]. 中国药物评价, 2023, 40(6): 470-479.
[3]	李丽, 刘婉如, 张征, 江志杰, 李宁. 逐瘀通脉胶囊对大鼠急性局灶性脑缺血再灌注损伤的影响[J]. 中国药物评价, 2023, 40(6): 502-505.
[4]	颜若曦. 《PIC/S生物技术检查备忘录》分析与探讨[J]. 中国药物评价, 2023, 40(6): 537-540.
[5]	甘加明, 邹瑜, 黄丹, 陈冬华, 严全鸿. 基于流池法的氨糖美辛肠溶片体外溶出行为研究[J]. 中国药物评价, 2023, 40(6): 480-484.
[6]	徐桂连, 董斌, 韩春晖, 郝爱鱼. 磷酸苯丙哌林多晶型制备、表征及平衡溶解度研究[J]. 中国药物评价, 2023, 40(6): 489-493.
[7]	代琪, 李康曦, 叶俏波, 文永盛, 许莉, 李及. 僵蚕化学成分、药理作用及毒理学研究进展[J]. 中国药物评价, 2023, 40(5): 402-408.
[8]	赵磊, 杨铭, 王皓, 马彧, 马金刚, 姜大成, 王路宏, 昝珂. 沙棘不同采收期与不同干燥过程真菌毒素的考察及其风险评估[J]. 中国药物评价, 2023, 40(5): 377-383.
[9]	洪淑华, 林琪珊, 柴将红, 潘红炬. 佐匹克隆有关物质及其校正因子影响因素的测定研究[J]. 中国药物评价, 2023, 40(5): 384-388.
[10]	李悦忱, 崔韶婧, 赵月然. 高效液相色谱-柱后光化学衍生法测定活血止痛胶囊中黄曲霉毒素的含量[J]. 中国药物评价, 2023, 40(5): 390-395.
[11]	田洁, 郝爱鱼, 鹿麟, 邹翩, 董斌. 几种药物配伍对常见塑料包装输液产品中不溶性微粒的影响研究[J]. 中国药物评价, 2023, 40(5): 396-401.
[12]	杨艳青, 陈春梅, 陈伟, 吴瑞, 王学昌, 段莲. 信迪利单抗一线治疗晚期非小细胞肺癌的快速卫生技术评估[J]. 中国药物评价, 2023, 40(5): 409-415.
[13]	江依帆, 陈丽萍, 张若钰, 巫培豪, 邱嘉珉, 宣建伟, 毕惠嫦. 抑酸药物的临床综合评价指标体系构建[J]. 中国药物评价, 2023, 40(5): 416-421.
[14]	华敏凡, 宋沧桑, 李兴德, 陆维, 毛盼盼, 王国徽. 服药依从性预测模型临床应用研究进展[J]. 中国药物评价, 2023, 40(5): 422-425.
[15]	黄波, 曹晓明. 等渗与低渗造影剂对老年肾功能损伤患者行冠脉造影术的安全性临床观察[J]. 中国药物评价, 2023, 40(5): 426-429.